(Q51914073)

17 April 2018

title

Clinical predictors of response to pharmacotherapy with selective serotonin reuptake inhibitors in obsessive-compulsive disorder. (English)

1 reference

17 April 2018

obsessive-compulsive disorder

main subject

pharmacotherapy

0 references

serotonin

0 references

1 reference

3

Aslihan Polat

1 reference

17 April 2018

author name string

Raşit Tükel

1

1 reference

17 April 2018

Oya Bozkurt

2

1 reference

17 April 2018

Aysun Genç

4

1 reference

17 April 2018

Hatice Atli

5

1 reference

17 April 2018

publication date

1 August 2006

1 reference

17 April 2018

Psychiatry and Clinical Neurosciences

published in

1 reference

17 April 2018

volume

60

1 reference

17 April 2018

issue

4

1 reference

17 April 2018

page(s)

404-409

1 reference

17 April 2018

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

Clinical predictors of drug response in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

Insight and resistance in patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

Concomitant obsessive-compulsive disorder and schizotypal personality disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

The Yale-Brown Obsessive Compulsive Scale. II. Validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

Side effects as predictors of drug response in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

Insight and treatment outcome in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

Hoarding and Treatment Response in 38 Nondepressed Subjects With Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

Effect of Axis II Diagnoses on Treatment Outcome With Clomipramine in 55 Patients With Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01523.X

10.1111/J.1440-1819.2006.01523.X

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018